{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T10:16:52Z","timestamp":1781345812355,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Diabetes patients with peripheral neuropathy run increased risk of developing Charcot arthropathy (Charcot), often associated with foot fractures. Bone morphogenic proteins (BMPs) are among the most important regulators of bone homeostasis and fracture repair but have not been investigated in the pathophysiology of Charcot. The current study aims to address this issue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Sixteen patients diagnosed with active Charcot were treated with total contact cast (TCC) and monitored during 24 months (M) with repeated plain radiographs and magnetic resonance imaging (MRI). Plasma was sampled at 9 occasions and analyzed for BMP-1, BMP-2, BMP-3, BMP-4, BMP-6, BMP-7 and BMP-9 as well as for basal laboratory data. Fifteen diabetes patients with peripheral neuropathy and fifteen healthy participants without diabetes served as controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All Charcot patients had pathologically low BMP-2 level at inclusion which remained suppressed throughout the 2-year follow-up as defined by being lower than 2 standard deviations (SD) of BMP-2 in healthy controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and in diabetes patients with neuropathy without Charcot (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.002). BMP-2 did not differ between the control groups. BMP-7 in Charcot patients increased significantly 6\u201312 months following TCC treatment. Other BMPs showed no significant differences between the groups at any point during the follow-up.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Low BMP-2 in diabetes patients with neuropathy is associated with increased risk of developing Charcot fractures due to the critical role of BMP-2 for the initiation of bone repair. BMP-7 appears to partly compensate for the lack of response by other osteogenic BMPs during fracture repair in Charcot patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00592-025-02573-5","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T11:13:20Z","timestamp":1758107600000},"page":"123-131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low bone morphogenic protein-2 in diabetes patients with peripheral neuropathy is a correlated risk factor for the development of Charcot arthropathy"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6807-5795","authenticated-orcid":false,"given":"Jean","family":"Cassuto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnetha","family":"Folestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"\u00c5lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Asteberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"G\u00f6thlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"2573_CR1","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.2337\/dc21-2508","volume":"45","author":"W Jeffcoate","year":"2022","unstructured":"Jeffcoate W, Game F (2022) The Charcot foot reflects a response to injury that is critically distorted by preexisting nerve damage: an imperfect storm. Diabetes Care 45:1691\u20131697","journal-title":"Diabetes Care"},{"key":"2573_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11914-015-0286-8","volume":"13","author":"H Jiao","year":"2015","unstructured":"Jiao H, Xiao E, Graves DT (2015) Diabetes and its effect on bone and fracture healing. Curr Osteoporos Rep 13:327\u2013335","journal-title":"Curr Osteoporos Rep"},{"key":"2573_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s11914-019-00528-8","volume":"17","author":"AT Beeve","year":"2019","unstructured":"Beeve AT, Brazill JM, Scheller EL (2019) Peripheral neuropathy as a component of skeletal disease in diabetes. Curr Osteoporos Rep 17:256\u2013269","journal-title":"Curr Osteoporos Rep"},{"key":"2573_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.injury.2011.03.031","volume":"42","author":"R Marsell","year":"2011","unstructured":"Marsell R, Einhorn TA (2011) The biology of fracture healing. Injury 42:551\u2013555","journal-title":"Injury"},{"key":"2573_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrrheum.2014.164","volume":"11","author":"TA Einhorn","year":"2015","unstructured":"Einhorn TA, Gerstenfeld LC (2015) Fracture healing: mechanisms and interventions. Nat Rev Rheumatol 11:45\u201354","journal-title":"Nat Rev Rheumatol"},{"key":"2573_CR6","first-page":"100239","volume":"22","author":"D Dardari","year":"2020","unstructured":"Dardari D (2020) An overview of charcot\u2019s neuroarthropathy. J Clin Transl Endocrinol 22:100239","journal-title":"J Clin Transl Endocrinol"},{"key":"2573_CR7","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1007\/s00264-018-4153-y","volume":"42","author":"I Dumic-Cule","year":"2018","unstructured":"Dumic-Cule I, Peric M, Kucko L, Grgurevic L, Pecina M, Vukicevic S (2018) Bone morphogenetic proteins in fracture repair. Int Orthop 42:2619\u20132626","journal-title":"Int Orthop"},{"key":"2573_CR8","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.3390\/jcm10194597","volume":"10","author":"T Fuchs","year":"2021","unstructured":"Fuchs T, Stolberg-Stolberg J, Michel PA et al (2021) Effect of bone morphogenetic Protein-2 in the treatment of long bone Non-Unions. J Clin Med 10:4597","journal-title":"J Clin Med"},{"key":"2573_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jot.2015.08.001","volume":"4","author":"S Cecchi","year":"2016","unstructured":"Cecchi S, Bennet SJ, Arora M (2016) Bone morphogenetic protein-7: review of signalling and efficacy in fracture healing. J Orthop Translat 4:28\u201334","journal-title":"J Orthop Translat"},{"key":"2573_CR10","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/ng1916","volume":"38","author":"K Tsuji","year":"2006","unstructured":"Tsuji K, Bandyopadhyay A, Harfe BD et al (2006) BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38:1424\u20131429","journal-title":"Nat Genet"},{"key":"2573_CR11","doi-asserted-by":"publisher","first-page":"101723","DOI":"10.1016\/j.bonr.2023.101723","volume":"19","author":"J Cassuto","year":"2023","unstructured":"Cassuto J, Folestad A, Gothlin J, Malchau H, Karrholm J (2023) The importance of BMPs and TGF-betas for endochondral bone repair - A longitudinal study in hip arthroplasty patients. Bone Rep 19:101723","journal-title":"Bone Rep"},{"key":"2573_CR12","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm E, Altman DG, Egger M et al (2014) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 12:1500","journal-title":"Int J Surg"},{"key":"2573_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0894-1130(12)80176-1","volume":"6","author":"S Weinstein","year":"1993","unstructured":"Weinstein S (1993) Fifty years of somatosensory research: from the Semmes-Weinstein monofilaments to the Weinstein enhanced sensory test. J Hand Ther 6:11\u201322 discussion 50","journal-title":"J Hand Ther"},{"key":"2573_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1475-097X.1996.tb00733.x","volume":"16","author":"P Samuelsson","year":"1996","unstructured":"Samuelsson P, Blohme G, Fowelin J, Eriksson JW (1996) A new non-invasive method using pulse oximetry for the assessment of arterial toe pressure. Clin Physiol 16:463\u2013467","journal-title":"Clin Physiol"},{"key":"2573_CR15","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.12659\/MSM.905958","volume":"24","author":"DB Liu","year":"2018","unstructured":"Liu DB, Sui C, Wu TT, Wu LZ, Zhu YY, Ren ZH (2018) Association of bone morphogenetic protein (BMP)\/Smad signaling pathway with fracture healing and osteogenic ability in senile osteoporotic fracture in humans and rats. Med Sci Monit 24:4363\u20134371","journal-title":"Med Sci Monit"},{"key":"2573_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bone.2010.03.012","volume":"47","author":"YY Yu","year":"2010","unstructured":"Yu YY, Lieu S, Lu C, Colnot C (2010) Bone morphogenetic protein 2 stimulates endochondral ossification by regulating periosteal cell fate during bone repair. Bone 47:65\u201373","journal-title":"Bone"},{"key":"2573_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.joca.2013.01.009","volume":"21","author":"MM Caron","year":"2013","unstructured":"Caron MM, Emans PJ, Cremers A et al (2013) Hypertrophic differentiation during chondrogenic differentiation of progenitor cells is stimulated by BMP-2 but suppressed by BMP-7. Osteoarthritis Cartilage 21:604\u2013613","journal-title":"Osteoarthritis Cartilage"},{"key":"2573_CR18","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1152\/physrev.00028.2017","volume":"98","author":"JW Lowery","year":"2018","unstructured":"Lowery JW, Rosen V (2018) The BMP pathway and its inhibitors in the skeleton. Physiol Rev 98:2431\u20132452","journal-title":"Physiol Rev"},{"key":"2573_CR19","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/jcb.22412","volume":"109","author":"B Shen","year":"2010","unstructured":"Shen B, Wei A, Whittaker S et al (2010) The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro. J Cell Biochem 109:406\u2013416","journal-title":"J Cell Biochem"},{"key":"2573_CR20","doi-asserted-by":"publisher","first-page":"e21353","DOI":"10.1096\/fj.202001264R","volume":"35","author":"AG Furlan","year":"2021","unstructured":"Furlan AG, Spanou CES, Godwin ARF et al (2021) A new MMP-mediated prodomain cleavage mechanism to activate bone morphogenetic proteins from the extracellular matrix. FASEB J 35:e21353","journal-title":"FASEB J"},{"key":"2573_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bone.2009.03.656","volume":"45","author":"K Lavery","year":"2009","unstructured":"Lavery K, Hawley S, Swain P, Rooney R, Falb D, Alaoui-Ismaili MH (2009) New insights into BMP-7 mediated osteoblastic differentiation of primary human mesenchymal stem cells. Bone 45:27\u201341","journal-title":"Bone"},{"key":"2573_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1046\/j.1523-1755.2002.00103.x","volume":"61","author":"SE Gould","year":"2002","unstructured":"Gould SE, Day M, Jones SS, Dorai H (2002) BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 61:51\u201360","journal-title":"Kidney Int"},{"key":"2573_CR23","doi-asserted-by":"publisher","first-page":"121114","DOI":"10.1016\/j.biomaterials.2021.121114","volume":"277","author":"H Newman","year":"2021","unstructured":"Newman H, Shih YV, Varghese S (2021) Resolution of inflammation in bone regeneration: from Understandings to therapeutic applications. Biomaterials 277:121114","journal-title":"Biomaterials"},{"key":"2573_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/ten.teb.2015.0357","volume":"22","author":"AW James","year":"2016","unstructured":"James AW, LaChaud G, Shen J et al (2016) A review of the clinical side effects of bone morphogenetic Protein-2. Tissue Eng Part B Rev 22:284\u2013297","journal-title":"Tissue Eng Part B Rev"},{"key":"2573_CR25","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00264-011-1301-z","volume":"35","author":"SN Lissenberg-Thunnissen","year":"2011","unstructured":"Lissenberg-Thunnissen SN, de Gorter DJ, Sier CF, Schipper IB (2011) Use and efficacy of bone morphogenetic proteins in fracture healing. Int Orthop 35:1271\u20131280","journal-title":"Int Orthop"},{"key":"2573_CR26","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s11999-013-3261-7","volume":"472","author":"MS Fourman","year":"2014","unstructured":"Fourman MS, Borst EW, Bogner E, Rozbruch SR, Fragomen AT (2014) Recombinant human BMP-2 increases the incidence and rate of healing in complex ankle arthrodesis. Clin Orthop Relat Res 472:732\u2013739","journal-title":"Clin Orthop Relat Res"},{"key":"2573_CR27","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1177\/1071100714536166","volume":"35","author":"T Rearick","year":"2014","unstructured":"Rearick T, Charlton TP, Thordarson D (2014) Effectiveness and complications associated with Recombinant human bone morphogenetic Protein-2 augmentation of foot and ankle fusions and fracture nonunions. Foot Ankle Int 35:783\u2013788","journal-title":"Foot Ankle Int"},{"key":"2573_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3113\/FAI.2009.0597","volume":"30","author":"C Bibbo","year":"2009","unstructured":"Bibbo C, Patel DV, Haskell MD (2009) Recombinant bone morphogenetic protein-2 (rhBMP-2) in high-risk ankle and hindfoot fusions. Foot Ankle Int 30:597\u2013603","journal-title":"Foot Ankle Int"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-025-02573-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-025-02573-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-025-02573-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:11:50Z","timestamp":1769515910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-025-02573-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["2573"],"URL":"https:\/\/doi.org\/10.1007\/s00592-025-02573-5","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest, financial or otherwise, to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}